These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30815845)

  • 21. Intermittent fasting protects the nigral dopaminergic neurons from MPTP-mediated dopaminergic neuronal injury in mice.
    Ojha U; Khanal S; Park PH; Hong JT; Choi DY
    J Nutr Biochem; 2023 Feb; 112():109212. PubMed ID: 36370926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease.
    Jarras H; Bourque M; Poirier AA; Morissette M; Coulombe K; Di Paolo T; Soulet D
    J Neuroendocrinol; 2020 Jan; 32(1):e12782. PubMed ID: 31430407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice.
    Radisavljevic N; Metcalfe-Roach A; Cirstea M; Tabusi MM; Bozorgmehr T; Bar-Yoseph H; Finlay BB
    mSphere; 2024 Jan; 9(1):e0037923. PubMed ID: 38078745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model.
    Bousquet M; Gibrat C; Saint-Pierre M; Julien C; Calon F; Cicchetti F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1401-8. PubMed ID: 19632286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson's disease mice by gut microbiome.
    Shan J; Qu Y; Wang S; Wei Y; Chang L; Ma L; Hashimoto K
    Brain Res Bull; 2021 Dec; 177():103-110. PubMed ID: 34560239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
    Jiang Z; Wang X; Zhang H; Yin J; Zhao P; Yin Q; Wang Z
    MedComm (2020); 2023 Jun; 4(3):e268. PubMed ID: 37200942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Microbiota Transplantation from Aged Mice Render Recipient Mice Resistant to MPTP-Induced Nigrostriatal Degeneration Via a Neurogenesis-Dependent but Inflammation-Independent Manner.
    Qiao CM; Zhou Y; Quan W; Ma XY; Zhao LP; Shi Y; Hong H; Wu J; Niu GY; Chen YN; Zhu S; Cui C; Zhao WJ; Shen YQ
    Neurotherapeutics; 2023 Sep; 20(5):1405-1426. PubMed ID: 37596429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota.
    Liu J; Zhang Y; Ye T; Yu Q; Yu J; Yuan S; Gao X; Wan X; Zhang R; Han W; Zhang Y
    J Agric Food Chem; 2022 Jan; 70(1):184-195. PubMed ID: 35016506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
    Li C; Biswas S; Li X; Dutta AK; Le W
    J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orally Induced High Serum Level of Trimethylamine N-oxide Worsened Glial Reaction and Neuroinflammation on MPTP-Induced Acute Parkinson's Disease Model Mice.
    Qiao CM; Quan W; Zhou Y; Niu GY; Hong H; Wu J; Zhao LP; Li T; Cui C; Zhao WJ; Shen YQ
    Mol Neurobiol; 2023 Sep; 60(9):5137-5154. PubMed ID: 37266763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.
    Moon M; Kim HG; Hwang L; Seo JH; Kim S; Hwang S; Kim S; Lee D; Chung H; Oh MS; Lee KT; Park S
    Neurotox Res; 2009 May; 15(4):332-47. PubMed ID: 19384567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis.
    Yang C; Wang W; Deng P; Wang X; Zhu L; Zhao L; Li C; Gao H
    CNS Neurosci Ther; 2023 Dec; 29(12):3815-3828. PubMed ID: 37334756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model.
    Pu Z; Liu S; Guo Z; Zhang X; Yan J; Tang Y; Xiao H; Gao J; Li Y; Bai Q
    Neuroscience; 2023 Aug; 524():120-136. PubMed ID: 37321369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons.
    Zhang T; Wang T; Chen X; Zhao Z; Chen Z
    Exp Ther Med; 2022 Jan; 23(1):52. PubMed ID: 34934429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
    Chung YC; Kim SR; Jin BK
    J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut-microbiota-brain axis.
    Pu Y; Wu Q; Zhang Q; Huang T; Wen J; Wei L; Hashimoto K; Liu Y
    Psychopharmacology (Berl); 2023 May; 240(5):1103-1118. PubMed ID: 36881113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series.
    Joers V; Masilamoni G; Kempf D; Weiss AR; Rotterman TM; Murray B; Yalcin-Cakmakli G; Voll RJ; Goodman MM; Howell L; Bachevalier J; Green SJ; Naqib A; Shaikh M; Engen PA; Keshavarzian A; Barnum CJ; Nye JA; Smith Y; Tansey MG
    Neurobiol Dis; 2020 Oct; 144():105027. PubMed ID: 32712266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.